Novo Nordisk reaches an agreement with Hims & Hers for anti-obesity drugs. Its stock price soars.
Peace made between the two pharmaceutical companies after many disagreements and lawsuits
Novo Nordisk gains 3% on the stock market. Its anti-obesity drug offers cardiac benefits. The Danish government cuts its economic forecasts.
The Danish company's drug Wegovy offers greater protection against heart risks than that of rival Eli Lilly.